Investor Orca Capital AG
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Orca Capital AG . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Date Form Target Prev
Shares
Current
Shares
Change
(Percent)
Ownership
(Percent)
Change
(Percent)
2025-09-19 13G/A CODX / Co-Diagnostics, Inc. 4,809,500 2,193,713
2025-09-18 13G CODX / Co-Diagnostics, Inc. 4,809,500
2025-09-15 13G/A 109,432
2025-09-15 13G 131,250
2025-09-09 13G/A PPBT / Purple Biotech Ltd - Depositary Receipt (Common Stock) 306,394
2025-09-09 13G PPBT / Purple Biotech Ltd - Depositary Receipt (Common Stock) 605,000
2025-08-07 13G/A PHIO / Phio Pharmaceuticals Corp. 514,965 280,642
2025-07-23 13G/A RANI / Rani Therapeutics Holdings, Inc. 4,354,000 1,891,623
2025-07-17 13G/A SXTP / 60 Degrees Pharmaceuticals, Inc. 166,229
2025-07-17 13G SXTP / 60 Degrees Pharmaceuticals, Inc. 320,000
2025-07-17 13G RANI / Rani Therapeutics Holdings, Inc. 4,354,000
2025-06-11 13G/A VERO / Venus Concept Inc. 0 101,748
2025-06-11 13G/A VERO / Venus Concept Inc. 0 108,680
2025-05-09 13G/A KTTA / Pasithea Therapeutics Corp. 362,857
2025-05-09 13G KTTA / Pasithea Therapeutics Corp. 371,142
2025-04-23 13G/A CANF / Can-Fite BioPharma Ltd. - Depositary Receipt (Common Stock) 375,000,000 157,382,700
2025-04-16 13G CANF / Can-Fite BioPharma Ltd. - Depositary Receipt (Common Stock) 375,000,000
2025-04-14 13G/A VERO / Venus Concept Inc. 0
2025-04-11 13G VERO / Venus Concept Inc. 83,429
2025-03-17 13G/A DWTX / Dogwood Therapeutics, Inc. 69,821
2025-03-17 13G DWTX / Dogwood Therapeutics, Inc. 115,790
2025-02-18 13G/A LIXT / Lixte Biotechnology Holdings, Inc. 120,012
2025-02-13 13G LIXT / Lixte Biotechnology Holdings, Inc. 217,392
2025-02-04 13G/A ENVB / Enveric Biosciences, Inc. 97,019
2025-02-04 13G ENVB / Enveric Biosciences, Inc. 166,667
2025-02-04 13G/A SPCB / SuperCom Ltd. 124,583
2025-02-03 13G/A SGLY / Singularity Future Technology Ltd. 0
2025-01-31 13G SPCB / SuperCom Ltd. 272,727
2025-01-28 13G SGLY / Singularity Future Technology Ltd. 233,334
2025-01-23 13G PHIO / Phio Pharmaceuticals Corp. 514,965
2025-01-21 13G/A BHAT / Blue Hat Interactive Entertainment Technology 9,200,000 0
2025-01-16 13G BHAT / Blue Hat Interactive Entertainment Technology 9,200,000